Literature DB >> 17483072

Compound heterozygote (C282Y/H63D) of hereditary hemochromatosis in a 16-year-old girl with hypoplastic kidney.

Barbara Kaczorowska-Hac1, Katarzyna Sikorska, Krzysztof P Bielawski, Krystyna Schramm, Anna Balcerska.   

Abstract

Iron-overload diseases are associated with primary or secondary disturbances of iron metabolism. Hereditary hemochromatosis, a genetically heterogeneous disease that is characterized by increased iron absorption and progressive deposition in parenchymal cells, may lead to organ damage and failure. Molecular studies have shown that hemochromatosis type 1 is predominantly due to a mutation in the HFE gene; there are 2 major mutations (C282Y and H63D). Disease symptoms are observed mostly after 40 years of age, often in men. We report the unusual case of a 16-year-old girl with an elevated serum iron level and a hypoplastic kidney. Identification of heterozygosity for the HFE gene mutation C282Y/H63D confirmed the diagnosis of hemochromatosis type 1. The early detection of hemochromatosis in the presented case may delay organ damage and failure due to iron overload.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483072     DOI: 10.1532/IJH97.E0605

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

Review 1.  Hereditary hemochromatosis: update for 2003.

Authors:  Stephen A Harrison; Bruce R Bacon
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

2.  Anemia of chronic disease: a misnomer.

Authors:  R F Schilling
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

Review 3.  Genetic haemochromatosis: genes and mutations associated with iron loading.

Authors:  Clara Camaschella; Antonella Roetto; Marco De Gobbi
Journal:  Best Pract Res Clin Haematol       Date:  2002-06       Impact factor: 3.020

4.  Interpretation of iron studies in adolescent haemochromatosis.

Authors:  P R Catterson; G P Summerfield; J R Beesley
Journal:  Clin Lab Haematol       Date:  1999-04

5.  A population-based study of the clinical expression of the hemochromatosis gene.

Authors:  J K Olynyk; D J Cullen; S Aquilia; E Rossi; L Summerville; L W Powell
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

6.  Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin.

Authors:  D K Moczulski; W Grzeszczak; B Gawlik
Journal:  Med Sci Monit       Date:  2001 May-Jun

7.  A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment.

Authors:  S M McDonnell; B L Preston; S A Jewell; J C Barton; C Q Edwards; P C Adams; R Yip
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

8.  A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population.

Authors:  Maciej T Małecki; Tomasz Klupa; Małgorzata Waluś; Wojciech Czogała; Paul Greenlaw; Jacek Sieradzki
Journal:  Med Sci Monit       Date:  2003-02

9.  Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation.

Authors:  M De Gobbi; R Caruso; F Daraio; F Chianale; R M Pinto; F Longo; A Piga; C Camaschella
Journal:  Eur J Pediatr       Date:  2002-12-10       Impact factor: 3.183

Review 10.  When and how should we screen for hereditary hemochromatosis?

Authors:  Gérard Chalès; Pascal Guggenbuhl
Journal:  Joint Bone Spine       Date:  2003-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.